Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 166,000 | 248,000 | 96,000 | 272,000 | 208,000 |
| Depreciation Amortization | 133,000 | 91,000 | 45,000 | 176,000 | 131,000 |
| Income taxes - deferred | -14,000 | -20,000 | 27,000 | 53,000 | 31,000 |
| Accounts receivable | -91,000 | -36,000 | 28,000 | 26,000 | 61,000 |
| Accounts payable and accrued liabilities | 42,000 | 13,000 | 5,000 | 6,000 | 11,000 |
| Other Working Capital | -58,000 | -32,000 | -1,000 | -83,000 | -48,000 |
| Other Operating Activity | 204,000 | 18,000 | -57,000 | -35,000 | -78,000 |
| Operating Cash Flow | $382,000 | $282,000 | $143,000 | $415,000 | $316,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42,000 | -26,000 | -10,000 | -83,000 | -45,000 |
| Purchase Of Investment | -1,296,000 | -975,000 | -717,000 | -1,136,000 | -896,000 |
| Sale Of Investment | 1,382,000 | 933,000 | 676,000 | 1,103,000 | 846,000 |
| Purchase Sale Intangibles | -9,000 | -7,000 | -6,000 | -8,000 | -14,000 |
| Other Investing Activity | 2,000 | -1,000 | -3,000 | 4,000 | -8,000 |
| Investing Cash Flow | $46,000 | $-69,000 | $-54,000 | $-112,000 | $-103,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -301,000 | -100,000 | -100,000 | -1,000 | -1,000 |
| Common Stock Repurchased | -7,000 | -7,000 | -7,000 | -8,000 | -7,000 |
| Dividend Paid | -55,000 | -55,000 | N/A | -58,000 | -58,000 |
| Other Financing Activity | -66,000 | -40,000 | 15,000 | -241,000 | -160,000 |
| Financing Cash Flow | $-429,000 | $-202,000 | $-92,000 | $-308,000 | $-226,000 |
| Exchange Rate Effect | 1,000 | N/A | N/A | 1,000 | 1,000 |
| Beginning Cash Position | 31,000 | 32,000 | 32,000 | 37,000 | 37,000 |
| End Cash Position | 31,000 | 43,000 | 30,000 | 32,000 | 24,000 |
| Net Cash Flow | $0 | $11,000 | $-2,000 | $-5,000 | $-13,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 382,000 | 282,000 | 143,000 | 415,000 | 316,000 |
| Capital Expenditure | -47,000 | -30,000 | -15,000 | -101,000 | -75,000 |
| Free Cash Flow | 335,000 | 252,000 | 128,000 | 314,000 | 241,000 |